Literature DB >> 32182389

Complement: Bridging the innate and adaptive immune systems in sterile inflammation.

Martin W Lo1, Trent M Woodruff1.   

Abstract

The complement system is a collection of soluble and membrane-bound proteins that together act as a powerful amplifier of the innate and adaptive immune systems. Although its role in infection is well established, complement is becoming increasingly recognized as a key contributor to sterile inflammation, a chronic inflammatory process often associated with noncommunicable diseases. In this context, damaged tissues release danger signals and trigger complement, which acts on a range of leukocytes to augment and bridge the innate and adaptive immune systems. Given the detrimental effect of chronic inflammation, the complement system is therefore well placed as an anti-inflammatory drug target. In this review, we provide a general outline of the sterile activators, effectors, and targets of the complement system and a series of examples (i.e., hypertension, cancer, allograft transplant rejection, and neuroinflammation) that highlight complement's ability to bridge the 2 arms of the immune system. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  C1q; alloimmunity; anaphylatoxins; cancer; hypertension; neuroinflammation

Year:  2020        PMID: 32182389     DOI: 10.1002/JLB.3MIR0220-270R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

Review 1.  COVID-19: Complement, Coagulation, and Collateral Damage.

Authors:  Martin W Lo; Claudia Kemper; Trent M Woodruff
Journal:  J Immunol       Date:  2020-07-22       Impact factor: 5.422

2.  Blood-brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses.

Authors:  Scott R Burks; Cymon N Kersch; Jaclyn A Witko; Michael A Pagel; Maggie Sundby; Leslie L Muldoon; Edward A Neuwelt; Joseph A Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

3.  An Immunoregulatory Role for Complement Receptors in Murine Models of Breast Cancer.

Authors:  Fazrena Nadia Md Akhir; Mohd Hezmee Mohd Noor; Keith Weng Kit Leong; Jamileh A Nabizadeh; Helga D Manthey; Stefan E Sonderegger; Jenny Nga Ting Fung; Crystal E McGirr; Ian A Shiels; Paul C Mills; Trent M Woodruff; Barbara E Rolfe
Journal:  Antibodies (Basel)       Date:  2021-01-08

Review 4.  Inflammation induces zebrafish regeneration.

Authors:  Maria Iribarne
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

5.  Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity.

Authors:  Emil Gregersen; Cristine Betzer; Woojin S Kim; Gergo Kovacs; Lasse Reimer; Glenda M Halliday; Steffen Thiel; Poul Henning Jensen
Journal:  J Neuroinflammation       Date:  2021-08-16       Impact factor: 8.322

6.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Complement C7 is Specifically Expressed in Mesangial Cells and is a Potential Diagnostic Biomarker for Diabetic Nephropathy and is Regulated by miR-494-3p and miR-574-5p.

Authors:  Hang Guo; Zhiyue Yan; Yonghui Hu; Xitong Huang; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-05       Impact factor: 3.168

Review 8.  Complement System in Alzheimer's Disease.

Authors:  Akash Shah; Uday Kishore; Abhishek Shastri
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

9.  Complement regulation in ovine lymph nodes during early pregnancy.

Authors:  Leying Zhang; Lidong Cao; Pengfei Feng; Xu Han; Ling Yang
Journal:  Exp Ther Med       Date:  2021-12-23       Impact factor: 2.447

Review 10.  Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement.

Authors:  Kurt R Stenmark; Maria G Frid; Evgenia Gerasimovskaya; Hui Zhang; Mary K McCarthy; Joshua M Thurman; Thomas E Morrison
Journal:  Pulm Circ       Date:  2021-05-18       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.